FDA Adverse Event Injury Summary report: N

VELA VENTILATOR

MDR report key: 6243092 · Received January 11, 2017

Report

Report Number
2021710-2017-05200
Event Type
Injury
Date Received
January 11, 2017
Date of Event
December 12, 2016
Report Date
April 24, 2017
Manufacturer
CAREFUSION, INC
Product Code
CBK
PMA / PMN Number
K093094
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). RESULTS OF INVESTIGATION: A CAREFUSION CERTIFIED FIELD SERVICE TECHNICIAN WAS ABLE TO DUPLICATE THE REPORTED COMPLAINT (UNIT REPORTED TO HAVE VENTILATOR INOPERABLE ALARM). THE REPORTED ISSUE WAS RESOLVED BY REPLACING THE MAIN PRINTED CIRCUIT BOARD. THE UNIT WAS TESTED AFTER THE REPLACEMENT AND THE DEVICE IS NOW WORKING TO MANUFACTURER SPECIFICATIONS. AT THIS TIME, CAREFUSION HAS NOT RECEIVED THE SUSPECT COMPONENT FOR EVALUATION. IF THE COMPONENT IS RETURNED THEN A SUPPLEMENTAL REPORT WILL BE SUBMITTED AFTER AN INVESTIGATION IS COMPLETED.

Additional Manufacturer Narrative · 1

THE SUSPECT COMPONENT (PRINTED CIRCUIT BOARD) WAS RETURNED TO CAREFUSION'S FAILURE ANALYSIS LABORATORY. THE INVESTIGATOR WAS UNABLE TO DUPLICATE THE REPORTED ISSUE. DURING INVESTIGATION, IT WAS DETERMINED THAT ALL OF THE TRANSDUCERS WERE RESPONDING TO PRESSURE INPUT APPROPRIATELY AND THE OUTPUT DIFFERENTIAL VOLTAGE (ODV) WAS WITHIN THE MANUFACTURER SPECIFICATION. NO FAILURES WERE DETECTED BUT IT WAS CONFIRMED IN THE EVENT LOGS THAT A TRANSDUCER FAULT HAD OCCURRED.

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT THE UNIT DISPLAYED VENTILATOR INOPERABLE ALARM UNEXPECTEDLY WHILE BEING USED ON THE PATIENT. THE REPORTED VENTILATOR WAS IMMEDIATELY REPLACED BY A BACKUP VENTILATOR. THE CUSTOMER REPORTED NO HARM OR INJURY TO THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
24566 VELA VENTILATOR VENTILATOR, CONTINUOUS, FACILITY USE CBK CAREFUSION, INC VELA VENTILATOR

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention